Balance Sheet
Cash Flow Statement
Capital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Accured ExpensesChange in CashChange in TaxesDeferred TaxesDepreciation & Amortization (CF)Depreciation and DepletionFree Cash FlowGains from Investment SecuritiesGains from Sales and DivestituresLong-Term Debt RepaymentsNet Cash FlowNet IncomeOther Working Capital ChangesOther financing activitiesSales of Property, Plant and EquipmentShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Amrep (AXR) Gains from Sales and Divestitures (2018 - 2026)

Amrep's Gains from Sales and Divestitures history spans 8 years, with the latest figure at $15715.0 for Q4 2025.

  • For Q4 2025, Gains from Sales and Divestitures rose 7.15% year-over-year to $15715.0; the TTM value through Oct 2025 reached $15715.0, up 7.15%, while the annual FY2025 figure was $500000.0, 0.0% changed from the prior year.
  • Gains from Sales and Divestitures for Q4 2025 was $15715.0 at Amrep, roughly flat from $15715.0 in the prior quarter.
  • Across five years, Gains from Sales and Divestitures topped out at $500000.0 in Q2 2021 and bottomed at $9833.0 in Q3 2022.
  • The 5-year median for Gains from Sales and Divestitures is $15190.5 (2024), against an average of $135792.9.
  • The largest annual shift saw Gains from Sales and Divestitures surged 115.79% in 2021 before it plummeted 52.03% in 2022.
  • A 5-year view of Gains from Sales and Divestitures shows it stood at $20500.0 in 2021, then tumbled by 52.03% to $9833.0 in 2022, then rose by 24.06% to $12199.0 in 2023, then grew by 20.22% to $14666.0 in 2024, then rose by 7.15% to $15715.0 in 2025.
  • Per Business Quant, the three most recent readings for AXR's Gains from Sales and Divestitures are $15715.0 (Q4 2025), $15715.0 (Q3 2025), and $500000.0 (Q2 2025).